オンライン配信アーカイブ

5) Early results of the clinical trial (LAPiS study) to transplant human iPS cell-derived cardiomyocyte transplantation to severe heart failure due to ischemic heart disease

Keiichi Fukuda (Keio University, Heartseed Inc.)